arrow
U

Uwe Platzbecker

university hospital leipzig
H指数:87
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bone health in myelodysplastic neoplasms: results from the prospective longitudinal BoHemE study

骨髓增生异常性肿瘤的骨骼健康:来自前瞻性纵向BoHemE研究的结果

Leukemia
IF13.4
2026-10-090
OAAI
Canakinumab or emavusertib for anemia in lower-risk MDS: results of the CANFIRE and LUCAS phase 2, open-label, multicenter trials

卡那奴单抗或依马伏塞替治疗低危骨髓增生异常综合征贫血:CANFIRE和LUCAS两项2期、开放标签、多中心试验的结果

2026-09-160
OAAI
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study

吉列替尼与异基因造血干细胞移植序贯治疗复发/难治FMS样酪氨酸激酶3(FLT3)突变急性髓系白血病患者的多中心真实世界研究

2026-09-050
OAAI
Allogeneic hematopoietic cell transplantation for myelodysplastic syndromes harboring a paroxysmal nocturnal hemoglobinuria clone—a study on behalf of the Chronic Malignancies and Severe Aplastic Anemia Working Parties of the EBMT

异基因造血细胞移植治疗伴有阵发性睡眠性血红蛋白尿克隆异常的骨髓增生异常综合征——欧洲血液和骨髓移植学会慢性恶性病和重症再生障碍性贫血工作组代为研究

2026-08-130
PRE
Low muscle quality, but not muscle mass, in abdominal CT-scans associates with adverse outcomes in AML patients undergoing an allogeneic stem cell transplantation

腹部CT扫描显示肌肉质量低而非肌肉量与接受异基因干细胞移植的AML患者的不良预后相关

2026-08-130
OAAI
Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT

非清髓性预处理与减低强度预处理在≥65岁急性髓系白血病患者异基因造血干细胞移植中的比较:EBMT ALWP的研究

2026-06-210
PRE
Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells

克隆性造血不影响嵌合抗原受体(CAR)T细胞的制备

2026-06-030
OAAI
Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution

基于分子演化的骨髓增生异常综合征预后评分

2026-05-262
PRE
Preclinical efficacy of tasquinimod in myelodysplastic neoplasms: Restoring erythropoiesis and mitigating bone loss

tasquinimod在骨髓增生异常肿瘤中的临床前疗效:恢复红细胞生成和减轻骨质流失

2026-04-140
OA
Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes

治疗相关细胞减少症与低危骨髓增生异常综合征患者对imetelstat临床反应之间的关联

2026-04-070
OAAI
Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myeloma

克隆性造血的复发、TP53 扩增以及之前的来那度胺治疗是驱动多发性骨髓瘤患者 CAR-T 治疗后髓系障碍的因素。

Leukemia
IF13.4
2026-03-240
OAAI
American Society of Hematology 2026 guidelines for treating newly diagnosed acute myeloid leukemia in older adults

Sekeres, M.A.; Mattison, R.J.; Artz, A.S.; Baer, M.R.; Chua, C.C.; Demichelis-Gomez, R.; Egan, P.C.; Fletcher, L.; Foucar, C.E.; Garcia, J.S.; et al. 美国血液学会2025年关于老年新诊断急性髓系白血病治疗的指南。Blood Adv. 2025. [Google Scholar] [CrossRef]

2026-03-130
OAAI
MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-cel

MyCARdiac评分:整合心脏成像和生物标志物以预测接受cilta-cel治疗的RRMM患者的结局

Leukemia
IF13.4
2026-02-170
OAAI
Antileukemic therapies for older adults with AML ineligible for conventional therapy: systematic review & meta-analysis

不适合常规治疗的老年AML患者的抗白血病治疗: 系统评价和荟萃分析

2026-01-190
OAAI
Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat

接受伊美替拉stat治疗低风险骨髓增生异常新生物患者的克隆性负荷调节

Leukemia
IF13.4
2026-01-120
OAAI
Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report

造血干细胞移植对于实现再生障碍性贫血后髓系肿瘤的长期生存有效:欧洲血液和骨髓移植学会严重再生障碍性贫血报告

2026-01-010
OA
Aligning Clinical Trial Reporting: A systematic analysis and position statement by the International Consortium for MDS

协调临床试验报告:国际骨髓增生异常综合征联盟的系统分析及立场声明

Blood
IF23.1
2026-01-010
PRE
The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantation

12 Gy全身照射和环磷酰胺的顺序不会影响接受骨髓 ablative 异基因干细胞移植的AML患者的结局

2025-12-020
OAAI
Inflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasia

炎症性基质细胞和T细胞介导克隆性造血和骨髓增生异常综合征中的人类骨髓微环境重塑

2025-11-180
OAAI